Based on this background, we have settled a study to investigate whether a LIF/LIFR axis regulates the transcription of FGFR4 via STAT3 phosphorylation, leading to an aberrantly expression of FGFR4 especially in the histological intestinal subtype of GC. The gene discussed is LIF; the disease is gastric cancer.